Цитирование
Emicizumab enables rapid tolerance, reducing bleeding during low-dose ITI in pediatric hemophilia A. // Blood Vessels, Thrombosis & Hemostasis. – URL: https://www.sciencedirect.com/science/article/pii/S2950327226000653?dgcid=rss_sd_all
Emicizumab enables rapid tolerance, reducing bleeding during low-dose ITI in pediatric hemophilia A. Blood Vessels, Thrombosis & Hemostasis. https://www.sciencedirect.com/science/article/pii/S2950327226000653?dgcid=rss_sd_all
“Emicizumab enables rapid tolerance, reducing bleeding during low-dose ITI in pediatric hemophilia A.” Blood Vessels, Thrombosis & Hemostasis.
@article{article38721,
title = {Emicizumab enables rapid tolerance, reducing bleeding during low-dose ITI in pediatric hemophilia A},
journal = {Blood Vessels, Thrombosis \& Hemostasis},
url = {https://www.sciencedirect.com/science/article/pii/S2950327226000653?dgcid=rss_sd_all}
}